Oslo, Norway, 22 May 2025 In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 22th of May, the Company’s Chair of the Board, Øyvin Brøymer, has received open proxies…
ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head,…
Aurora, CO, April 18, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This release is for informational purposes…
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating…
PANAMA CITY, April 17, 2026 /PRNewswire/ -- Despite a turbulent first quarter characterized by market…
ASHBURN, Va., April 16, 2026 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading enterprise technology…
The initiative is designed to support the tokenization and commercialization of 100 companies formed around…